Trial intelligence / Profile preview

Nitroglycerin for Prevention of Radial Artery Occlusion in Pediatrics

NCT05443061Completed

Sponsor
Seoul National University Hospital
Start
Sep 2022
Primary completion
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of nitroglycerin in Radial artery occlusion (RAO) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Incidence of radial arterial occlusion. Started Sep 2022; status: completed.

02

Drugs

nitroglycerin
03

Conditions

Radial artery occlusion (RAO)

Beyond the preview

Go deeper on NCT05443061.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05443061.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call